A Trial to Determine Whether Two Differing Strength Tablets (3 x 5 mg Versus 1 x 15 mg) of Sublingually Org 5222 (Asenapine) Are Safe and Equal in Subjects With Schizophrenia or Schizoaffective Disorder (P05937)
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Schizophrenia
Related studies linked through entity extraction aliases.
Effects of Galantamine on Cognition
- Status
- COMPLETED
- Phase
- PHASE2
6-week Trial of the Efficacy and Safety of Asenapine Compared to Placebo in Participants With an Acute Exacerbation of Schizophrenia (P06124)
- Status
- COMPLETED
- Phase
- PHASE3
A Drug Interaction Study of Valproic Acid and Paliperidone Extended-Release (ER) in Patients With Schizophrenia, Bipolar I Disorder, or Schizoaffective Disorder
- Status
- COMPLETED
- Phase
- PHASE1
Effect of Varenicline on Cognitive Function in Cigarette Smokers With Schizophrenia
- Status
- COMPLETED
- Phase
- PHASE2
Factors Association With Poor Physical Function in Older Adults With Schizophrenia
- Status
- COMPLETED
- Phase
- N/A
A Placebo-Controlled Study of Physiologic Effects of L-methylfolate in Schizophrenia Patients
- Status
- COMPLETED
- Phase
- NA
Pharmacokinetics, Effect of Food, Safety and Tolerability of a New Tablet Formulation of GSK1144814 in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Zyprexa® Relprevv™ Patient Care Program
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
A Study in Schizophrenia Patients
- Status
- COMPLETED
- Phase
- PHASE2
Is MS14 Helpful in Schizophrenia?
- Status
- UNKNOWN
- Phase
- PHASE2
Effects of Pravastatin on Cholesterol, Inflammation and Cognition in Schizophrenia
- Status
- COMPLETED
- Phase
- PHASE4
Digoxin Drug-Drug Interaction With Lurasidone HCl
- Status
- COMPLETED
- Phase
- PHASE1
The Bioequivalence Of Two Different Lurasidone Formulations In Patients
- Status
- COMPLETED
- Phase
- PHASE1
Prevention of Relapse With Injectable Paliperidone Palmitate Versus Oral Antipsychotics
- Status
- COMPLETED
- Phase
- PHASE3
Assertive Community Treatment (ACT) in Schizophrenia Spectrum Disorders
- Status
- COMPLETED
- Phase
- PHASE4
Trial for Antidepressant Treatment for Negative Symptom of Schizophrenia With NRG1 Risk Genotype
- Status
- UNKNOWN
- Phase
- PHASE4
Cognitive Remediation Therapy and Schizophrenia
- Status
- COMPLETED
- Phase
- NA
A Study of a Remediation Program of Social Cognition in Schizophrenia
- Status
- TERMINATED
- Phase
- PHASE2
Expanding Rapid Ascertainment Networks of Schizophrenia Families in Taiwan
- Status
- COMPLETED
- Phase
- N/A